ATXN2 and amyotrophic lateral sclerosis: All follow-up studies confirmed the association of the ATXN2 polyQ expansions with ALS risk in various ethnic populations, including North Americans, Europeans, French-Canadians and Chinese [14], [15], [16], [17], [18], [19], [20].